Company Description
RNA Holdings Limited. The Group's principal activities are wholesaling and trading of gold bullion, gold ornaments, diamonds and other jewelry products. The Group's other activities are as follows: provision of loans, gold bullion financing, ...
Related Business Topics
| Oil and Gas Jobs | Plastic Recycling | Electric Power | |||
| Wind Energy | Solar Power | Propane | |||
| Aluminum Recycling | Oil and Gas | Oil and Gas Wholesale Distribution | |||
| Natural Gas Utilities | Electric Utility Jobs |
Breaking News
Reuters - November 09, 2009 3:00 PM
KJ VENLO, GERMANY, Nov 09 (MARKET WIRE) -- Transaction adds to QIAGEN's content engine for development of future diagnostics and boosts the Company's presence in pharma discovery and validation VENLO, The Netherlands, November 9, 2009 - QIAGEN N.V. ...
Reuters - November 09, 2009 3:00 PM
KJ VENLO, GERMANY, Nov 09 (MARKET WIRE) -- Transaction adds to QIAGEN's content engine for development of future diagnostics and boosts the Company's presence in pharma discovery and validation VENLO, The Netherlands, November 9, 2009 - QIAGEN N.V. ...
USA Today - November 05, 2009 11:14 AM
The era of the robot scientist may soon be upon us. Two teams of human scientists Thursday unveiled their work with robots that not only perform experiments, but also come up with new ones. The prototypes tackled physics and biology problems that require ...
Reuters - November 02, 2009 6:11 AM
BOTHELL, WA, Nov 02 (MARKET WIRE) -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, will hold a conference call to report third quarter 2009 financial results on Monday, Nov. 9, 2009, at 9:30 a.m. Eastern time (6:30 a.m. Pacific ...
Reuters - September 02, 2009 7:17 AM
PHILADELPHIA, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that insufficient votes were obtained for passage of proposal no. 3 contained in the proxy for the 2009 Annual Meeting of Stockholders. With this ...
